These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1098 related items for PubMed ID: 17705185

  • 21. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens.
    Hoff J, Bani-Sadr F, Gassin M, Raffi F.
    Clin Infect Dis; 2001 Mar 15; 32(6):963-9. PubMed ID: 11247719
    [Abstract] [Full Text] [Related]

  • 23. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V.
    J Med Virol; 2010 Feb 15; 82(2):206-12. PubMed ID: 20029819
    [Abstract] [Full Text] [Related]

  • 24. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA.
    Int J STD AIDS; 2009 May 15; 20(5):336-8. PubMed ID: 19386971
    [Abstract] [Full Text] [Related]

  • 25. Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire.
    N'Dri-Yoman T, Anglaret X, Messou E, Attia A, Polneau S, Toni T, Chenal H, Seyler C, Gabillard D, Wakasugi N, Eholié S, Danel C.
    Antivir Ther; 2010 May 15; 15(7):1029-34. PubMed ID: 21041918
    [Abstract] [Full Text] [Related]

  • 26. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E, Calabresi A, Lapadula G, Tirelli V, Costarelli S, Cologni G, Zaltron S, Puoti M, Carosi G, Torti C.
    Antivir Ther; 2008 May 15; 13(3):341-8. PubMed ID: 18572746
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.
    Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK.
    J Infect; 2007 Feb 15; 54(2):185-91. PubMed ID: 16564573
    [Abstract] [Full Text] [Related]

  • 28. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK, Comanor L, White C, Kipnis P, Elkin C, Leung K, Ocampo A, Attar N, Keiser P, Lee WM.
    J Viral Hepat; 2007 Mar 15; 14(3):176-82. PubMed ID: 17305883
    [Abstract] [Full Text] [Related]

  • 29. High prevalence of occult hepatitis B in Baltimore injection drug users.
    Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL.
    Hepatology; 2004 Jan 15; 39(1):51-7. PubMed ID: 14752822
    [Abstract] [Full Text] [Related]

  • 30. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF.
    J Gastroenterol Hepatol; 2010 Jan 15; 25(1):101-6. PubMed ID: 19817965
    [Abstract] [Full Text] [Related]

  • 31. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.
    Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U.
    Eur J Gastroenterol Hepatol; 2008 Jul 15; 20(7):668-73. PubMed ID: 18679070
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK, 903 Study Team, 907 Study Team.
    J Infect Dis; 2004 Apr 01; 189(7):1185-92. PubMed ID: 15031786
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J.
    J Med Virol; 2004 Jun 01; 73(2):195-9. PubMed ID: 15122792
    [Abstract] [Full Text] [Related]

  • 34. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep 01; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 35. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec 01; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 36. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb 01; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 37. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, Atabak S, Amini M, Khadem-Sadegh A, Ramezani A.
    Ther Apher Dial; 2010 Jun 01; 14(3):349-53. PubMed ID: 20609190
    [Abstract] [Full Text] [Related]

  • 38. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
    Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J, EuroSIDA.
    J Antimicrob Chemother; 2010 Mar 01; 65(3):548-55. PubMed ID: 20051475
    [Abstract] [Full Text] [Related]

  • 39. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P, Trabaud MA, Pradat P, Lebouché B, Chevallier M, Chevallier P, Zoulim F, Trepo C.
    Clin Infect Dis; 2007 Sep 01; 45(5):624-32. PubMed ID: 17682999
    [Abstract] [Full Text] [Related]

  • 40. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB, Torresi J, Lemoh C, Biggs BA.
    J Med Virol; 2008 Sep 01; 80(9):1565-9. PubMed ID: 18649341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.